You are here

Home » Reports

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 81 - 90 of 650 results
 
  • Record 1 TO 650

  1. Pharmacophore-Modeled Screening for HbF-Inducing Agents

    SBC: Gene Regulation Laboratories            Topic: N/A

    DESCRIPTION (provided by applicant): Induction of endogenous fetal globin (HbF) can ameliorate the clinical severity of the beta globin disorders. Many short chain fatty acids and derivatives (SCFADs) stimulate activity from the fetal globin gene promoter, and some create an accessible chromatin structure through HDAC inhibition and histone hyperacetylation. However, the available SCFA drugs requi ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  2. HA Based Opsonokines:A Novel Approach to Tumor Vaccines

    SBC: Genitrix, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): A number of academic groups and companies have focused on the production of cell-based tumor vaccines by cytokine gene transfer. This approach allows sustained local production of the cytokine and maintains a high conc

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  3. Integrated Methods to Discover Novel Disease Pathways

    SBC: OSCIENT PHARMACEUTICALS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Our goal is to accelerate the rate of discovery of novel therapeutic agents by rapidly assigning function to genes with no experimental functional data (NEFD) and organizing them within Protein Interaction Network (PIN

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  4. Effects of SNPs on Gene Regulation in Complex Diseases

    SBC: OSCIENT PHARMACEUTICALS CORPORATION            Topic: N/A

    N/A

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  5. Controlled Ethanol Cell Culture System

    SBC: GINER INC            Topic: N/A

    DESCRIPTION (provided by applicant): Controlled exposure of primary and cultured cells to ethanol is an important experimental aspect of current biomolecular level research for the treatment of alcohol use disorders such as alcohol dependence and alcoh

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  6. PORTABLE ISLET CULTURE SYS

    SBC: GINER INC            Topic: N/A

    N/A

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  7. PORTABLE ISLET CULTURE SYS

    SBC: GINER INC            Topic: N/A

    N/A

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  8. Direct Methanol Fuel Cells for Wheelchair Applications

    SBC: GINER INC            Topic: N/A

    DESCRIPTION (provided by applicant): The development of a lightweight power supply, based on direct methanol fuel cell (DMFC) technology, for use in a powered pediatric mobility device is proposed. The fuel cell system would replace the lead acid batte

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  9. Cylinder-Free Atmosphere Control for Incubators

    SBC: GINER INC            Topic: N/A

    DESCRIPTION (provided by applicant): In this Phase I SBIR program, the feasibility of a novel electrochemical oxygen and carbon dioxide control system, providing variable, cylinder-free, incubator control will be demonstrated by Giner, Inc. The goal is

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  10. Fluorosome Technique for Drug Permeability Studies

    SBC: GLSynthesis Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): We have validated a novel method, the "Fluorosome-trans Technique", to measure membrane permeabilities of drugs. The results for 47-marketed drugs show high correlation with human oral absorption. This method empl

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government